The Effectiveness of Recombinant Human Erythropoietin (EPO) Treatment in a Neonate with Hyporegenerative Anemia Following Rh Isoimmunization in Spite of Normal Serum Epo Level

Author： Erduran Erol   Bahadir Aysenur  

Publisher： Informa Healthcare

ISSN： 1521-0669

Source： Pediatric Hematology and Oncology, Vol.28, Iss.8, 2011-10, pp. : 721-722

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urinary Erythropoietin Concentrations after Early Short-Term Infusion of High-Dose Recombinant Epo for Neuroprotection in Preterm Neonates

By  

Neonatology, Vol. 102, Iss. 3, 2012-07 ,pp. : 172-177

Karger

Access to resources Recommend Favorite

SUCCESSFUL TREATMENT OF NEONATAL RHESUS HEMOLYTIC ANEMIA WITH HIGH DOSES OF RECOMBINANT HUMAN ERYTHROPOIETIN

By Wacker Pierre   Ozsahin Hulya   Stelling Maire-José   Humbert James  

Pediatric Hematology and Oncology, Vol. 18, Iss. 4, 2001-06 ,pp. : 279-282

Informa Healthcare

Access to resources Recommend Favorite

Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair)

By  

Neonatology, Vol. 108, Iss. 3, 2015-08 ,pp. : 198-204

Karger

Access to resources Recommend Favorite

NO RESPONSE TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY IN PATIENTS WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I

By Tamary Hannah   Tiqva Petah   Shalev Hanna   Pinsk Vered   Sheva Beer   Zoldan Meira   Zaizov Rina   Tiqva Petah  

Pediatric Hematology and Oncology, Vol. 16, Iss. 2, 1999-03 ,pp. : 165-168

Informa Healthcare

Access to resources Recommend Favorite

Recombinant Human Erythropoietin β: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients

By Durmaz Oguzhan   Demirkaya Metin   Sevinir Betül  

Pediatric Hematology and Oncology, Vol. 28, Iss. 6, 2011-08 ,pp. : 461-468

Informa Healthcare

Access to resources Recommend Favorite